Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.
Gynecol Oncol. 2005 Oct;99(1):50-7. doi: 10.1016/j.ygyno.2005.05.023.
Gynecol Oncol. 2005.
PMID: 16023182
Clinical Trial.
A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with asymptomatic CA125 progression after first-line chemotherapy of epithelial ovarian cancer.
Ghamande SA, Silverman MH, Huh W, Behbakht K, Ball G, Cuasay L, Würtz SO, Brunner N, Gold MA.
Ghamande SA, et al.
Gynecol Oncol. 2008 Oct;111(1):89-94. doi: 10.1016/j.ygyno.2008.06.028. Epub 2008 Aug 28.
Gynecol Oncol. 2008.
PMID: 18760451
Clinical Trial.
Item in Clipboard
Prevalence and determinants of type 2 diabetes among Filipino-Americans in the Houston, Texas metropolitan statistical area.
Cuasay LC, Lee ES, Orlander PP, Steffen-Batey L, Hanis CL.
Cuasay LC, et al.
Diabetes Care. 2001 Dec;24(12):2054-8. doi: 10.2337/diacare.24.12.2054.
Diabetes Care. 2001.
PMID: 11723082
Item in Clipboard
Cite
Cite